Interestingly, rivastigmine administration increased appetite by increasing acyl-ghrelin/des-acyl-ghrelin ratio in AD patients (Furiya et al., 2018) implying AD-related cachexia could potentially be alleviated by promoting appetite through ghrelin administration. Here, GHRL is linked to Alzheimer disease.